Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 15 Jul 2025 | Wolfgang Philipp Principal Adviser | Symbio’s intention is to have brincidofovir in the EU market, as soon as possible | — |
| 15 Jul 2025 | Wolfgang Philipp Principal Adviser | Symbio’s intention is to have brincidofovir in the EU market, as soon as possible | SRC |
Mission & Goals
We aim to develop excellent new drugs and deliver them to patients as soon as possible. Please see the company website; https://www.symbiopharma.com/en/
EU Legislative Interests
Discussions with the Health Emergency Preparedness and Response Authority (HERA) regarding the organisation’s pharmaceutical development programs.
Communication Activities
Potential meetings with HERA.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
The Federation of Pharmaceutical Manufacturers' Associations of JAPAN.
Organisation Members
(i) SymBio Pharma USA, Inc., a corporation registered in the State of Delaware, USA, with address 2530 Meridian Parkway, Suite 300, Durham, North Carolina 27713, USA, and (ii) SymBio Pharma Ireland Limited, a corporation registered in Ireland, with registered address at 19, Baggot Street Lower, Dublin 2, Ireland, D02 X658.
Additional Information
Average salary per employee: EUR 300,000. Total office and administrative costs per employee: EUR 4,000. Annual amount spent on interest representation activities: 0.05 FTE * EUR 304,000/year = EUR 15,200.